LAG3 and Miyoshi myopathy: Taken together, these results identify the functional relevance of blocking GAL-3 on MM cells as a means to enhance effector T-cell activities, and also provide the rationale for targeting GAL-3 (on MM tumor cells) in combination with LAG3 (on effector T cells) to further enhance MM-specific immune responses and anti-tumor activities.